Literature DB >> 31488840

Autosomal dominant tubulointerstitial kidney disease.

Olivier Devuyst1,2, Eric Olinger3, Stefanie Weber4, Kai-Uwe Eckardt5, Stanislav Kmoch6, Luca Rampoldi7, Anthony J Bleyer8.   

Abstract

Autosomal dominant tubulointerstitial kidney disease (ADTKD) is a recently defined entity that includes rare kidney diseases characterized by tubular damage and interstitial fibrosis in the absence of glomerular lesions, with inescapable progression to end-stage renal disease. These diseases have long been neglected and under-recognized, in part due to confusing and inconsistent terminology. The introduction of a gene-based, unifying terminology led to the identification of an increasing number of cases, with recent data suggesting that ADTKD is one of the more common monogenic kidney diseases after autosomal dominant polycystic kidney disease, accounting for ~5% of monogenic disorders causing chronic kidney disease. ADTKD is caused by mutations in at least five different genes, including UMOD, MUC1, REN, HNF1B and, more rarely, SEC61A1. These genes encode various proteins with renal and extra-renal functions. The mundane clinical characteristics and lack of appreciation of family history often result in a failure to diagnose ADTKD. This Primer highlights the different types of ADTKD and discusses the distinct genetic and clinical features as well as the underlying mechanisms.

Entities:  

Mesh:

Year:  2019        PMID: 31488840     DOI: 10.1038/s41572-019-0109-9

Source DB:  PubMed          Journal:  Nat Rev Dis Primers        ISSN: 2056-676X            Impact factor:   52.329


  45 in total

Review 1.  Improving Molecular Therapy in the Kidney.

Authors:  Jeffrey D Rubin; Michael A Barry
Journal:  Mol Diagn Ther       Date:  2020-08       Impact factor: 4.074

2.  Disease Modeling To Understand the Pathomechanisms of Human Genetic Kidney Disorders.

Authors:  Elisa Molinari; John A Sayer
Journal:  Clin J Am Soc Nephrol       Date:  2020-03-05       Impact factor: 8.237

Review 3.  Regulation of polycystin expression, maturation and trafficking.

Authors:  Jinghua Hu; Peter C Harris
Journal:  Cell Signal       Date:  2020-04-08       Impact factor: 4.315

4.  Autosomal dominant tubulointerstitial kidney disease: a new tool to guide genetic testing.

Authors:  Kaice A LaFavers; Tarek M El-Achkar
Journal:  Kidney Int       Date:  2020-09       Impact factor: 10.612

5.  Meta-GWAS Reveals Novel Genetic Variants Associated with Urinary Excretion of Uromodulin.

Authors:  Christina B Joseph; Marta Mariniello; Ayumi Yoshifuji; Guglielmo Schiano; Jennifer Lake; Jonathan Marten; Anne Richmond; Jennifer E Huffman; Archie Campbell; Sarah E Harris; Stephan Troyanov; Massimiliano Cocca; Antonietta Robino; Sébastien Thériault; Kai-Uwe Eckardt; Matthias Wuttke; Yurong Cheng; Tanguy Corre; Ivana Kolcic; Corrinda Black; Vanessa Bruat; Maria Pina Concas; Cinzia Sala; Stefanie Aeschbacher; Franz Schaefer; Sven Bergmann; Harry Campbell; Matthias Olden; Ozren Polasek; David J Porteous; Ian J Deary; Francois Madore; Philip Awadalla; Giorgia Girotto; Sheila Ulivi; David Conen; Elke Wuehl; Eric Olinger; James F Wilson; Murielle Bochud; Anna Köttgen; Caroline Hayward; Olivier Devuyst
Journal:  J Am Soc Nephrol       Date:  2022-03       Impact factor: 10.121

Review 6.  Rare genetic causes of complex kidney and urological diseases.

Authors:  Emily E Groopman; Gundula Povysil; David B Goldstein; Ali G Gharavi
Journal:  Nat Rev Nephrol       Date:  2020-08-17       Impact factor: 28.314

7.  A Comprehensive Map of mRNAs and Their Isoforms across All 14 Renal Tubule Segments of Mouse.

Authors:  Lihe Chen; Chun-Lin Chou; Mark A Knepper
Journal:  J Am Soc Nephrol       Date:  2021-03-04       Impact factor: 10.121

Review 8.  Complexity and Specificity of Sec61-Channelopathies: Human Diseases Affecting Gating of the Sec61 Complex.

Authors:  Mark Sicking; Sven Lang; Florian Bochen; Andreas Roos; Joost P H Drenth; Muhammad Zakaria; Richard Zimmermann; Maximilian Linxweiler
Journal:  Cells       Date:  2021-04-27       Impact factor: 6.600

Review 9.  Renal Ciliopathies: Sorting Out Therapeutic Approaches for Nephronophthisis.

Authors:  Marijn F Stokman; Sophie Saunier; Alexandre Benmerah
Journal:  Front Cell Dev Biol       Date:  2021-05-13

Review 10.  Role of transcription factor hepatocyte nuclear factor-1β in polycystic kidney disease.

Authors:  Annie Shao; Siu Chiu Chan; Peter Igarashi
Journal:  Cell Signal       Date:  2020-02-14       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.